Featured

  • January 3, 2024
  • North America
  • Healthcare

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

WEST LAFAYETTE, IND – January 3, 2024 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the appointment of Scott Huennekens as Executive Chairperson of the Board. A 30-year…

Read More

  • November 16, 2023
  • North America
  • Healthcare

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection

WEST LAFAYETTE, IN – November 16, 2023 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the completion of a $30 million Series C financing. This significant investment…

Read More

All Releases

Reset Filters

  • September 19, 2023
  • North America
  • Healthcare

Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility

EAST BRUNSWICK, N.J. – September 19, 2023 – Rising Pharma Holdings Inc., dba as Rising Pharmaceuticals, today announced the opening of a commercial manufacturing facility in Decatur, Illinois, to manufacture and package sterile products, including injectables and ophthalmic products in …

Read More

  • September 7, 2023
  • North America
  • Healthcare

Click Therapeutics Announces Collaboration with Indivior to Develop and Commercialize Novel Prescription Digital Therapeutics in Substance Use Disorders

NEW YORK – September 7, 2023 – Click Therapeutics today announced the execution of a new collaboration agreement with Indivior for the development and commercialization of prescription digital therapeutics to treat substance use disorders, beginning with Opioid Use Disorder (OUD). Through a …

Read More

  • August 23, 2023
  • North America
  • Healthcare

Leiters Health Ranks No. 2069 on the 2023 Inc. 5000

NEW YORK – August 23, 2023 – Inc. revealed today that Leiters Health ranks No. 2069 on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful …

Read More

  • July 31, 2023

Augmedics strengthens AR/AI portfolio with planned acquisition of Surgalign digital health assets

CHICAGO – July 31, 2023 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process. The …

Read More

  • July 3, 2023

Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution

BRIDGEWATER, NJ – July 3, 2023 – Nevakar Injectables Inc. (“Nevakar”), a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, announced today that the U.S. Food and Drug Administration (“FDA”) has approved …

Read More

  • June 7, 2023

Augmedics raises $82.5 million to accelerate adoption of augmented reality spine surgery

CHICAGO – June 27, 2023 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced the successful close of an $82.5 million Series D financing. The round was led by Dallas-based CPMG and adds Evidity Health Capital as …

Read More

  • May 4, 2023

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication

ROSEMONT, ILLINOIS – May 4, 2023 – Long Grove Pharmaceuticals announced the strategic in-licensing of Norepinephrine in 0.9% Sodium Chloride premix formulation from Nevakar Injectables, Inc. This manufactured, ready-to-use formulation is room-temperature stable and will be available in three commonly administered …

Read More

  • November 3, 2022
  • North America
  • Business Services

H.I.G. Capital Completes Acquisition of Celerion

MIAMI – November 3, 2022 – H.I.G. Capital (“H.I.G.”), a leading global investment firm with $52 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the acquisition of Celerion Holdings, Inc. (“Celerion” or …

Read More

  • September 13, 2022
  • North America

H.I.G. Capital Completes Recapitalization of Navitas Life Sciences

MIAMI – September 13, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences …

Read More

  • June 29, 2022
  • North America

Leiters Joins the End Drug Shortages Alliance

DENVER – June 29, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of compounded sterile preparations and pharmacy services, announced today it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The …

Read More

Displaying 10 of 193 News Articles

×